We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Immune Sensitivity Hampers Clinical Applications of CRISPR/Cas9

By LabMedica International staff writers
Posted on 12 Nov 2018
Print article
Image: The crystal structure of S. pyogenes Cas9 in complex with sgRNA and its target DNA at 2.5-Angstrom resolution (Photo courtesy of Wikimedia Commons).
Image: The crystal structure of S. pyogenes Cas9 in complex with sgRNA and its target DNA at 2.5-Angstrom resolution (Photo courtesy of Wikimedia Commons).
Findings presented in a recent paper suggest that use of the CRISPR/Cas9 gene-editing tool in clinical settings may be more complicated than previously thought, since most people have a pre-existing immune sensitivity to proteins from the bacterial source of Cas9.

CRISPR/Cas9 is regarded as the cutting edge of molecular biology technology. CRISPRs (clustered regularly interspaced short palindromic repeats) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacterial virus or plasmid. Since 2013, the CRISPR/Cas9 system has been used in research for gene editing (adding, disrupting, or changing the sequence of specific genes) and gene regulation. By delivering the Cas9 enzyme and appropriate guide RNAs (sgRNAs) into a cell, the organism's genome can be cut at any desired location. The conventional CRISPR/Cas9 system from Streptococcus pyogenes is composed of two parts: the Cas9 enzyme, which cleaves the DNA molecule and specific RNA guides that shepherd the Cas9 protein to the target gene on a DNA strand.

Streptococcus pyogenes is a common cause of infectious diseases in humans, but it has not been clear whether it induced a T-cell memory against the Cas9 nuclease. To address this question, investigators at Charité - Universitätsmedizin Berlin (Germany) tested healthy humans for the presence of T-cells that reacted to Cas proteins.

The investigators reported in the October 29, 2018, online edition of the journal Nature Medicine that they had detected the presence of a preexisting ubiquitous effector T-cell response directed toward the most widely used Cas9 homolog from S. pyogenes (SpCas9) within healthy humans. They characterized SpCas9-reactive T-cells within the CD4/CD8 compartments for multi-effector potency, cytotoxicity, and lineage determination. Furthermore, in-depth analysis of SpCas9-reactive T-cells revealed a high frequency of SpCas9-reactive regulatory T-cells that could mitigate SpCas9-reactive effector T-cell proliferation and function in vitro.

"The Cas9 protein, which is derived from Streptococcus bacteria, forms an integral part of the CRISPR-Cas9 system. As streptococcal infections are common in humans, we hypothesized that there might be a pre-existing immunological memory to Cas9," said senior author Dr. Michael Schmück-Henneresse, a junior group leader at Charité - Universitätsmedizin Berlin. "We have developed a test that will allow us to ensure that T-cell products can be used with confidence. It can be used to reliably determine whether the risk of an immune reaction is low."

Related Links:
Charité - Universitätsmedizin Berlin

Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
FLU/RSV Test
Humasis FLU/RSV Combo
New
Urine Strips
11 Parameter Urine Strips

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.